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Abstract 
Determining the structure of a protein by any method requires various contributions from 
experimental and computational sides. In a recent study, high-density cross-
linking/mass spectrometry (HD-CLMS) data in combination with ab initio structure 
prediction determined the structure of human serum albumin (HSA) domains, with an 
RMSD to X-ray structure of up to 2.5 Å, or 3.4 Å in the context of blood serum. This 
paper reports the blind test on the readiness of this technology through the help of 
Critical Assessment of protein Structure Prediction (CASP). We identified between 201-
381 unique residue pairs at an estimated 5% FDR (at link level albeit with missing site 
assignment precision evaluation), for four target proteins. HD-CLMS proved reliable 
once crystal structures were released. However, improvements in structure prediction 
using cross-link data were slight. We identified two reasons for this. Spread of cross-
links along the protein sequence and the tightness of the spatial constraints must be 
improved. However, for the selected targets even ideal contact data derived from crystal 
structures did not allow modellers to arrive at the observed structure. Consequently, the 
progress of HD-CLMS in conjunction with computational modeling methods as a 
structure determination method, depends on advances on both arms of this hybrid 
approach. 
Keywords: 
High-density cross-linking/mass spectrometry, chemical biology, protein cross-linking, 
protein structure, CASP, structural biology, computational biology, protein modeling 
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Abbreviations 
CLMS - cross-linking/mass spectrometry 
HD - high-density 
NHS - N-hydroxysuccinimide 
NMR - nuclear magnetic resonance 
sulfo-SDA, sulfo-NHS-diazirine, sulfosuccinimidyl 4,4’-azipentanoate 
FDR - false discovery rate 
MBS - model-based search 
HSA - human serum albumin 
RMSD - root-mean-square deviation 
CASP - Critical Assessment of protein Structure Prediction 
Tris - tris(hydroxymethyl)aminomethane 
PES - polyethersulphone 
IAA - iodoacetamide 
LTQ - linear trap quadrupole 
MS2 - tandem MS scan 
LC-MS - liquid chromatography mass spectrometry 
FM - free modelling 
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Introduction 
Cross-linking/mass spectrometry (CLMS) is a well-established, low-resolution technique 
for revealing protein interactions in protein complexes and studying protein 
conformational changes (1-16). In contrast, the use of CLMS to resolve the detailed 
tertiary protein structure, pioneered by Young et al. (17), is less well established. A 
limiting factor is the sparsity of CLMS data. For example, an earlier study from our 
laboratory found 0.07 links per residue (18). A possible culprit for the low data density is 
the NHS-ester based cross-linking chemistry used in most studies. These cross-linker 
reagents predominantly react with lysines, which results in linkage maps that are not 
sufficiently dense to define the detailed structure of proteins. 
 In a previous study, we showed that this limitation can be overcome by high-
density cross-linking using photoactivatable cross-linkers (19). This approach uses a 
heterobifunctional cross-linker, sulfo-SDA, which on one side carries an NHS-ester and 
a photoactivatable diazirine on the other side. The diazirine group forms a reactive 
carbene species upon UV-light activation that can react with any amino acid. The 
resulting increased data density opens up the possibility of determining tertiary protein 
structure, which we demonstrated by recapitulating the domain structures of  human 
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serum albumin (HSA) in purified form (RMSD to crystal structure of 2.5 Å) and in its 
native environment, blood serum (RMSD to crystal structure 3.4 Å) (19). 
 This proof-of-concept study triggered three questions: Would the high-density 
CLMS (HD-CLMS) method perform robustly on proteins with unknown structure? Would 
current structure prediction experts be able to improve their predictions using HD-CLMS 
data? What are the current technical shortcomings of our approach? 
To tackle these questions, we embarked on a blind study to evaluate the current 
capabilities of HD-CLMS in the context of the Critical Assessment of protein Structure 
Prediction (CASP) experiment. CASP evaluates the state-of-the art in protein modeling 
(20) by the following experiment: Can modeling groups blindly predict the structure of a 
protein if the structure is unknown to them? Modeling groups predict the structures of 
these proteins and then have their predictions assessed by independent evaluating 
scientists.  
In CASP11, the Organizing Committee generously offered to identify suitable 
protein targets for us, which would be sent to our laboratory and give us the opportunity 
to blindly test our cross-linking method. After putting the proteins through our CLMS 
pipeline, the Rappsilber lab then submitted CLMS data in the form of distance restraints 
and these were then offered to the prediction groups as additional data that they could 
use in their predictions.  
Here, we report the outcome of this experiment. In particular, 1) we analyzed 
whether the blindly generated cross-links fit the crystal structures; 2) we analyzed if 
CASP modeling groups were able to utilize the CLMS data in their predictions, which is 
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discussed in detail elsewhere (21); and 3) we identified technical shortcomings of high-
density cross-linking and the blind study approach taken here. Overcoming the issues of 
HD-CLMS might pave the way for transforming this hybrid approach into a tertiary 
structure determination method to complement X-ray crystallography, NMR, and cryo-
EM. 
Methods 
Proteins  
A total of nine proteins were received from five labs. YaaA (PDB|5CAJ) was received 
from the lab of Prof. Mark Wilson (Department of Biochemistry/Redox Biology, 
University of Nebraska), as a frozen solution (25 mM HEPES, pH 8.2, 100 mM KCl, 
6.89 mg/mL). Five proteins, 413472 (GS13694A), BACUNI_01052 (PDB|4QE0), 
RUMGNA_02398 (PDB|4QAN), SAV1486 (PDB|4QPV) and BACCAC_02064 
(PDB|4QHW), were received from the lab of Dr. Ashley M. Deacon (Joint Center for 
Structural Genomics (JCSG), Stanford Synchrotron Radiation Lightsource, Stanford 
University). All were received as previously frozen and thawed-in-transit solutions, with 
all comprised of a buffer containing 20 mM tris(hydroxymethyl)aminomethane (Tris), pH 
7.9, 150 mM NaCl, 0.5 mM tris(2-carboxethyl)phosphine (TCEP) and at concentrations 
of 2.3, 4.6, 5.2, 2.5 and 11 mg/mL, respectively. MmR495A (no structure in PDB) was 
received from the lab of Prof. Gaetano Montelione (Center for Advanced Biotechnology 
and Medicine, Rutgers University) as both a solid lyophilisate (from 20 mM NH4OAc) 
that had absorbed water during transit and also as a frozen solution on ice containing 
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10 mM Tris, pH 7.5, 100 mM NaCl, 10 mM DTT, 0.02% NaN3. Af1502 (PDB|5A1Q) was 
received from the lab of Dr. Jörg Martin (Max-Planck Institute for Developmental 
Biology, Tübingen) as a frozen solution of 30 mM MOPS, 250 mM NaCl, 10% glycerol, 
pH 7.2, 16 mg/mL. Laminin (PDB|4YEQ) was received from the lab of Prof. Deborah 
Fass (Department of Structural Biology, Weizmann Institute of Science) as a frozen 
solution on ice containing PBS and 10% glycerol, 2.4 mg/mL. 
Four of the six designated targets (BACUNI_01052, RUMGNA_02398, SAV1486 
and BACCAC_02064) were buffer-exchanged prior to cross-linking to remove Tris from 
the buffer. Buffer exchange was carried out using polyethersulphone (PES) 
ultracentrifugation devices for concentration of small-volume protein samples, Vivaspin 
500, 5000 MWCO, GE Healthcare. Protein concentration was estimated using a 
Nanodrop 1000 Spectrophotometer from Thermo Fisher Scientific, measuring at 280 
nm. 
 
Chemical cross-linking 
Each target was cross-linked using sulfo-SDA, using four different cross-linker to protein 
ratios (2:1, 1:1, 0.5:1 and 0.25:1, w/w) and four UV activation times (15, 30, 45 and 60 
minutes). Cross-linking was carried out in two-stages: firstly sulfo-SDA, dissolved in 
cross-linking buffer (20 mM HEPES-OH, 20 mM NaCl, 5 mM MgCl2, pH 7.8), was added 
to target protein (30 µg, 1 µg/µL) and left to react in the dark for 1h at room temperature. 
This allowed the reaction of lysine side chain amino groups but also hydroxyl groups in 
serine, threonine and tyrosine side chains, with the sulfo-NHS ester component of the 
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cross-linker. The diazirine group was then photo-activated using UV irradiation, at 365 
nm, from a UVP CL-1000 UV Crosslinker (UVP Inc.). Samples were spread onto the 
inside of Eppendorf tube lids by pipetting (covering the entire surface of the inner lid), 
placed on ice at a distance of 5 cm from the tubes and irradiated for either 15, 30, 45 or 
60 minutes. Following the reaction, half of each reaction condition sample was then 
pooled as a “mixed” sample (a total of 240 µg). The resulting cross-linked mixtures were 
then separated by electrophoresis using a NuPAGE 4-12% Bis-Tris gel, ran using MES 
running buffer and stained using Imperial Protein Stain from Thermo Scientific, a 
Coomassie blue stain. Protein monomer bands were excised from the gel, cut into 
pieces and then washed to remove Coomassie staining. Proteins were reduced with 20 
mM DTT, alkylated using 55 mM IAA and digested overnight using trypsin following 
standard protocols (7). Trypsin/Glu-C co-digestion (in-gel trypsin digestion, overnight at 
37 °C followed by addition of Glu-C for 6 hours at room temperature) was used for 
mixed samples of Targets 1 and 2. In addition, in-solution Glu-C digestion was used for 
mixed samples of Targets 2-4. Digests were desalted using self-made C18 StageTips 
(22) prior to mass spectrometric analysis. 
 
Mass spectrometry and data analysis 
Peptides were loaded directly onto a spray emitter analytical column (75 µm inner 
diameter, 8 µm opening, 250 mm length; New Objectives) packed with C18 material 
(ReproSil-Pur C18-AQ 3 µm; Dr Maisch GmbH, Ammerbuch-Entringen, Germany) using 
an air pressure pump (Proxeon Biosystems) (23). Mobile phase A consisted of water 
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and 0.1% formic acid. Mobile phase B consisted of acetonitrile and 0.1% formic acid. 
Peptides were loaded onto the column with 1% B at 700 nl/min flow rate and eluted at 
300 nl/min flow rate with a gradient: 1 minute linear increase from 1% B to 9% B; linear 
increase to 35% B in 169 minutes; 5 minutes increase to 85% B. Eluted peptides were 
sprayed directly into a hybrid linear ion trap - Orbitrap mass spectrometer (LTQ-Orbitrap 
Velos, Thermo Fisher Scientific). Peptides were analyzed using a “high/high” acquisition 
strategy, detecting peptides at high resolution in the Orbitrap and analyzing, also in the 
Orbitrap, the products of their CID fragmentation in the ion trap. Survey scan (MS) 
spectra were recorded in the Orbitrap at 100,000 resolution. The eight most intense 
signals in the survey scan for each acquisition cycle were isolated with an m/z window 
of 2 Th and fragmented with collision-induced dissociation (CID) in the ion trap. 1+ and 
2+ ions were excluded from fragmentation. Fragmentation (MS2) spectra were acquired 
in the Orbitrap at 7500 resolution. Dynamic exclusion was enabled with 90 seconds 
exclusion time and repeat count equal to 1. 
 
Data analysis 
Mass spectrometric raw files were processed into peak lists using MaxQuant version 
1.3.0.5 (24) using default parameters, except the setting for “Top MS/MS peaks per 100 
Da” being set to 100. Peak lists were searched against a database, comprising in each 
case only the sequence of the protein that was being analyzed using the cross-linking 
software Xi (https://github.com/Rappsilber-Laboratory/XiSearch) for identification of 
cross-linked peptides. Sequences were provided by the CASP Organizing Committee 
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and are available in the supplement. Search parameters were MS accuracy, 6 ppm; 
MS/MS accuracy, 20 ppm; enzyme, trypsin; specificity, fully tryptic; allowed number of 
missed cleavages, four; cross-linker, SDA; fixed modifications, none; variable 
modifications, carbamidomethylation on cysteine, oxidation on methionine, SDA-loop 
(SDA cross-link within a peptide that is also cross-linked to a separate peptide). Other 
SDA modifications (including those resulting from reaction with water and ammonia) 
were not included in the database search. In earlier work we identified very few such 
modifications and including these modifications served to increase search database 
size and also increase false positive identifications, which we were keen to avoid here. 
Linkage specificity for sulfo-SDA was assumed to be at lysine, serine, threonine, 
tyrosine and protein N-termini at one end, with the other end having no specificity, i.e. 
linking to any amino acid residue. A modified target-decoy search strategy was used to 
estimate FDR (7, 25) (Fischer and Rappsilber, unpublished observations). In short, 
unique residue pairs are scored on supporting PSMs by: 
𝑆𝑐𝑜𝑟𝑒&'()*+',-)& = 𝑆𝑐𝑜𝑟𝑒/012 
Before scoring residue pairs and applying an FDR at their level, the dataset is pre-
filtered by applying an FDR-based score cut-off for PSMs and a subsequent FDR-based 
score cut-off for unique peptide pairs (scored the same way as residue pairs based on 
supporting PSMs). This provides a means to do noise filtering and can increase the 
number of unique residue pairs that pass a given FDR. Optimal score cut-offs are 
automatically defined using xiFDR: https://github.com/lutzfischer/xiFDR. 
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The MS data have been deposited to the ProteomeXchange Consortium via the 
PRIDE partner repository with the dataset identifier PXD003643 (26). 
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Results and discussion 
Outline of the experiment 
We had the following objectives for participating in the CASP experiment:  
● Test the robustness of high-density CLMS (HD-CLMS) 
● Test HD-CLMS driven hybrid methods on difficult protein modeling targets 
● Identify methodological shortcomings 
To accomplish these goals, the CASP Organizing Committee identified four CASP 
target proteins (Tx781, Tx808, Tx767, Tx812, ranging from 204-420 residues in size) 
whose structures were known to the organizers but neither to our laboratory nor the 
participating modeling groups. Figure 1 shows the organization and timetable of the 
experiment.   
We cross-linked the CASP11 targets with the photoactivatable cross-linker sulfo-
SDA (19). We used a panel of different cross-linker to protein ratios and UV activation 
times to maximize the number of unique cross-links. We digested cross-linked proteins 
using trypsin and in some cases with trypsin/Glu-C double digestion or Glu-C alone (see 
Supplemental Text for details). We then subjected the peptide mixture to LC-MS/MS 
mass spectrometric analysis without an additional enrichment of cross-linked peptides 
using on average 4.2 days for acquisition. The data were searched against databases 
derived from the target protein sequences using Xi (27). We assess confidence using a 
target-decoy approach (Fischer and Rappsilber, unpublished observations). We 
identified cross-links at 5, 10 and 20% FDR and submitted the results to the CASP 
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organizers who made the data available to the modeling groups. At 5% FDR, we 
identified from 201-381 links for the target proteins. Thus, for the CASP proteins we 
identified from 0.63-1.2 links per residue, which is comparable to our previous HD-
CLMS study on HSA (19) (Table 1). The percentage of links with >11 residues 
sequence separation, which are most important for protein modeling, were also 
comparable (59-73% vs 66%, Table 2).  Notably, the analysis was not nearing complete 
detection of linked residue pairs as additional runs kept adding further unique residue 
pairs, as seen from saturation analysis (Figure 2). We validated our CLMS data against 
the crystal structures which became available after the CASP prediction season. 
 
Agreement between CLMS data and solved structures 
Our first objective is to compare the CLMS data with the crystal structures to test the 
robustness of high-density cross-linking in a blind experiment.  
CLMS experiments do not necessarily reflect the structure of a single conformer 
but instead reflect the different conformations in the ensemble. Thus, conformational 
flexibility has to be taken into account when translating the observed cross-links into 
residue-residue distances. Here we translate observed links into a 25 Å bound on the 
distance and hence linkable by photo-CLMS using sulfo-SDA, based on a prior analysis 
of HSA (19) (in this study, 25 Å is the distance at which the observed Cα-Cα distance 
distribution merges with the distribution obtained from decoy matches). 
With the exception of the first target, Tx781, the 5% FDR lists matched near 
perfectly to the crystal structures (Tx808 9%, Tx767 5% and Tx812 4% links >25 Å, 
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respectively, averaging to 6% error) (Figures 3 and 4). This deteriorated slightly when 
considering 10% FDR data (19%, n.d., 8%; links >25 Å, respectively, averaging to 
10.7% error) and further worsened for 20% FDR data (54%, 20%, 28%; links >25 Å, 
respectively, averaging to 34% error). We attribute the deviation of the computed to the 
experimentally assessed accuracy to our still small data sets. FDR using the target-
decoy approach relies on large data sets. We can see that this condition is not perfectly 
fulfilled here. For example, in the case of Tx808 data with 20% FDR added only links 
with very low score to the 10% FDR list, indicating that the data had been exhaustively 
matched already at 10% FDR. Note that many links are also much shorter than the 
upper distance bound of 25 Å (Figure 4).   
One explanation for why the crystal structure of Tx781 did not support the CLMS 
data to the same degree as the other proteins is that the shipping conditions were 
problematic. The protein arrived defrosted to the laboratory and required buffer 
exchange from Tris to HEPES. Both might have compromised the integrity of the protein 
structure. Possibly as a result of this or due to cross-linking, the protein was seen as 
highly aggregated on SDS-PAGE (Figure 3a). As a further possibility, the protein may 
have a different structure in solution from in crystal. Our current data do not allow these 
possibilities to be distinguished. 
A limitation of our current workflow is that we are missing a site assignment 
scoring and hence do not control for site assignment errors. Importantly, this does not 
affect the FDR estimation (decoys model well the distribution of long distance and 
hence likely false links) and we showed in earlier work that we were able to model HSA 
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domains despite site assignment ambiguities (19), nevertheless it may falsely elevate 
the total number of reported links.  
In conclusion however, we find good agreement between photo-CLMS and 
crystallography in this blind study. This suggests that HD-CLMS produces robust 
residue-residue constraint data. 
 
Protein structure modeling in CASP11 with CLMS data  
Our second objective was to test hybrid modeling methods on our high-density CLMS 
data, on very difficult modeling targets such as those used in CASP11. The proteins in 
CASP11 are difficult “free modeling” targets, because even state-of-the-art fold 
recognition methods are unable to confidently find template structures for template-
based modeling. Thus, predictors might use ab initio structure prediction, template-
based modeling, or a mix of the two approaches.  
A full report of this experiment from the protein modeling perspective is published 
elsewhere (21). For the 19 groups that participated in the CLMS-driven and the normal 
CASP experiment (where no CLMS data is provided), the CLMS data slightly improved 
the GDT_TS of the predicted models from 36.4 to 38.1 for the first and from 40.9 to 42.0 
for the best-of-five submitted models. The GDT_TS is a measure for the match of the 
prediction to the native structure and ranges from 0 (structures completely dissimilar) to 
100 (perfect match). Overall, improvement in modeling accuracy by CLMS-driven 
predictions is very small and the results suggest no clear improvement.  
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One explanation for this result is that the CASP11 target proteins were too 
difficult to model, for current state-of-the-art protein structure prediction methods even 
with accurate residue-residue restraint data. We tested this hypothesis by re-running the 
modeling experiments with idealized residue-residue constraints taken from the crystal 
structures (Figure 5). Note that we evaluated this experiment on the evaluation domains 
used in CASP11, which are comprised of the partial domains of the full-length protein 
targets. Even in this idealized scenario, only two out of seven evaluation domains were 
“foldable” (GDT_TS of the best predicted structural model is 50 or higher). Since the 
HD-CLMS constraints are inferior to the idealized constraints, both in density and spatial 
resolution, this data supports our assumption that the CASP11 targets were too difficult 
to fold for current structure prediction algorithms. 
 
Identification of methodological shortcomings  
Our third objective was to use the CASP experiment to identify any methodological 
shortcomings of our cross-linking approach. Our analysis of the high-density CLMS data 
revealed two potential issues with the current method: Uneven sequence coverage 
caused by uneven distribution of cleavage sites and cross-link bias against β-sheet 
regions.  
The issue of uneven sequence coverage was most prevalent for target Tx781 
(Figure 6a). Our analysis of the tryptic digestion sites shows that the absence of 
observed residue pairs correlates with low frequency of tryptic cleavage sites: up to 
residue 180 there are 18 tryptic cleavage sites resulting in 0.11 cross-links per residue. 
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For the remaining 224 residues, there were 31 tryptic digestion sites which results in a 
cross-link density of 0.69 cross-links per residue. The interplay of lysine and arginine 
residue positions influences whether a cross-linked peptide can be observed for mass 
spectrometry. For example, the resulting tryptic peptide of cross-linked K126 would be 
60 residues long, which is prohibitively long for ordinary mass spectrometry analysis. 
From the K/R distribution, we estimate a total of 111 residues (62% of the sequence up 
to residue 180, 26% of the total protein sequence) are thus theoretically inaccessible via 
trypsin digestion.  
We also tested the use of alternative proteases and double-digestion strategies 
to combat the issue of uneven sequence coverage (Supplemental Tables 1-4). 
Alternative digestion strategies including Glu-C, rather than relying on digestion by 
trypsin alone increased the number of cross-links (Table 3). This was particularly 
striking for the N-terminal domain of Tx781. Glu-C digestion increased the cross-link 
density from 0.11 to 0.43 links per residue at 5% FDR for the first 180 residues. Thus, 
our data suggests that alternative or multiple proteases might improve the lack in cross-
link density in some regions that is caused by uneven distribution of tryptic digestion 
sites. 
Another issue that we found was an apparent bias against cross-links in β-sheet 
regions. An extreme example is the target Tx808, where 54% of the residues in the 
crystal structure have β-sheet structure. The cross-links of this protein are 
predominantly in the loop region (Figure 4b). We would expect 80% of the cross-linked 
residue pairs to have at least one β-strand residue if cross-linking would be unbiased 
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with regard to secondary structure. However, we find only 64% of the cross-linked 
residue pairs to contain a β-sheet residue (170 of 265; 5% FDR). This β-sheet bias also 
holds for targets Tx767 and Tx812 (Figure 7a and b). We exclude Tx781 from analysis 
because of the issues discussed earlier. We hypothesized that this bias against β-sheet 
residues might be caused by lack of tryptic cleavage sites, but found that this would only 
explain the apparent lack in β-sheet cross-links for Tx767 (Figure 7c). We next 
considered relative solvent accessibility (RSA) (28, 29) and whether this could explain 
discrepancies in expected and observed cross-link patterns. On average, β-strand 
residues have much lower relative solvent accessible areas in each of the targets (16-
19%) as opposed to other residues (34-40%) (Figure 7d and e). Consequently, both 
lack of anchoring residues, cleavage sites and lower RSA may contribute in different 
ratios and in different proteins to the problem of β-sheet analysis by CLMS. In addition, 
there is a fundamental issue concerning the use of sulfo-SDA as cross-linker (Figure 
6b). The α-carbon distance between adjacent hydrogen bonded beta strands is in the 
order of 5 Å (30), however the upper limit distance boundary defined by sulfo-SDA is in 
the range of 20 to 25 Å. This covers as much as five beta strands. Consequently, sulfo-
SDA, especially at current data density, is insufficient to reveal the topology of β-strands 
in a β-sheet. 
 
Conclusions  
Our test of high-density CLMS under the auspices of CASP11 led to three major 
insights. HD-CLMS can be conducted in under a week and delivers highly reliable 
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structural data on proteins in solution. Nevertheless, while sulfo-SDA proved very useful 
in solving the structure of the alpha-helical domains of HSA (19), HD-CLMS at large 
may require major developments to achieve a similar success for β-sheet proteins. 
Sequence coverage and spatial resolution pose a technological challenge and spell out 
the agenda for future developments. Finally, HD-CLMS is part of a hybrid workflow that 
relies on structure modeling. Future blind experiments to assess the current value of 
this hybrid approach need to select protein targets with structures that can be modeled 
at least when ideal data is available.  
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Figure legends and tables 
 
 
 
Figure 1. Organization of CASP11 including cross-linking/mass spectrometry.  
(a) Schematic representation of the interactions between CASP11 participants. (b) 
CASP11 and CLMS timeline. Total duration of CASP11 and CLMS denoted by the pink 
bar. Duration of organizational aspects denoted by the red bar. Duration of the cross-
linking and mass spectrometry aspect denoted by the green bar. Numbers within the 
timeline bars denote the number of days in duration for that particular element. 
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Figure 2. Saturation analysis: Residue pair identifications accumulated over runs. 
(a) – (d) Total number of unique residue pairs (5% FDR) increases with each 
successive LC-MS run. The order of LC-MS runs in the series was permutated 100 
times and the mean increase per run in all permutations is plotted. (a) Target 1-Tx781. 
(b) Target 2-Tx808. (c) Target 3-Tx767. (d) Target 4-Tx812. 
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Figure 3. Target cross-linking FDR estimation analysis.  
(a) CASP11 targets (Tx781, Tx808, Tx767 and Tx812), with (+) and without (-) sulfo-
SDA cross-linking.   (b) FDR analysis and quality control. FDR estimation on blind data 
given by the purple columns. Three confidence levels were provided for each target: 
high (95% true positive hits), medium (90% true positive hits) and low (80% true positive 
hits). Black and grey columns represent the results of a data QC check by the CASP 
Organizing Committee, following submission of cross-linking data by 3DP Lab 
Edinburgh. Numbers on top of black and grey columns represent the percentage of 
cross-links found in the known crystal structure that had Cα-Cα cross-linking distances 
of over 25 Å. (c) Cross-link networks for four CASP targets shown for estimated 5% 
FDR cut-off. Constraints with Cα-Cα cross-linking distances less than 25 Å are shown in 
purple, constraints with distances 25 Å and over are shown in green and constraints 
missing from the crystal structure and therefore unverifiable are represented in black. 
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Figure 4. Cross-link distribution within CASP11 Targets.  
(a) – (d) Left panel shows cross-linked residue pairs at 5% FDR. Right panel shows C-
alpha distance distribution of observed constraints at 5% FDR against the random 
constraint distribution. Constraints with Cα-Cα cross-linking distances less than 25 Å 
are shown in purple and constraints with distances 25 Å and over are shown in green. 
(a) Cross-linked residue pairs of Tx781 in PDB|4qan, n = 305. (b) Cross-linked residue 
pairs of Tx808 in PDB|4qhw, n = 265. (c) Cross-linked residue pairs of Tx767 in 
PDB|4qpv, n = 381. (d) Cross-linked residue pairs of Tx812 in crystal structure 
(structure not deposited in PDB), n = 201. 
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Figure 5. Decoy quality with idealized constraints.  
Distribution of GDT_TS scores for decoys generated by RBO Aleph without the help of 
constraints (blue), with cross-links (25Å, red) and native contacts (8Å, green) for the 
CASP11 cross-linking targets. The GDT_TS of the best model found in CASP11, which 
also includes template methods is indicated by the red line. 
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Figure 6. Procedural limitations identified in the study.  
(a) Top left: Constraints under 25 Å shown in purple, in the crystal structure of Tx781 
(PDB|4qan). Top right: Zoom of a 61 amino acid tryptic peptide devoid of observed 
constraints, containing a single, centrally located lysine residue highlighted in red. 
Bottom: Amino acid sequence of Tx781. Tryptic (lys and arg) residues highlighted in 
red. (b) Left: Tx808 crystal structure (PDB|4qhw). Right: Required and actual range of 
sulfo-SDA to resolve β-sheet topologies. 
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Figure 7. Beta strand analysis for targets Tx808, Tx767, Tx812.  
(a) Percentage of residues with beta strand structure. (b) Percentage of residue pairs 
where both residues are beta strand in identified cross-link data compared with the 
dataset where all possible residue pairs are considered. Residue pairs identified at 5% 
FDR shown by purple columns. All possible residue pairs with both residues in beta 
strand shown by grey columns. (c) Percentage of Lys and Arg residues in beta strands 
versus residues with all other structure types. Percentages of Lys and Arg residues 
across all residues for each target are shown by blue columns. Percentages of Lys and 
Arg residues in beta strands for each target are shown by grey columns. Percentage of 
Lys and Arg residues for all residues, excluding those with beta strand structure are 
shown by black columns. Numbers within columns refer to the numbers of Lys and Arg 
found in the crystal structure of each target. (d) Average relative solvent accessible area 
(RSA) of residues for each target in beta strands compared with average RSA for all 
other residues, excluding beta strand residues. Average RSAs of beta strand residues 
are shown by grey columns. Average RSAs of all other residues, excluding beta strand 
residues, are shown by black columns. (e) Average RSA of Lys, Ser, Thr and Tyr 
residues for each target, with RSA values of these residues in beta strands compared 
with values for residues in all other residues, excluding beta strand residues. Beta 
strand Lys, Ser, Thr and Tyr are shown by grey columns. Lys, Ser, Thr and Tyr from all 
other residues, excluding beta strand residues, are shown by black columns. Numbers 
within columns refer to the number of each type of residue found in the crystal structure 
of each target. 
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Table 1: Acquisition times and cross-link densities at different FDR rates 
Target protein MS 
acquisition 
time 
Links per 
residue at 5% 
FDR (number of 
residue pairs) 
Links per 
residue at 10% 
FDR (number of 
residue pairs) 
Links per 
residue at 20% 
FDR (number of 
residue pairs) 
HSA (585 AA) 12 days 0.85 (500) 1.51 (881) 2.56 (1495) 
Tx781 (420 AA) 4.7 days 0.73 (305) 1.06 (444) 1.35 (565) 
Tx808 (418 AA) 4.4 days 0.63 (265) 0.68 (286) 0.82 (342) 
Tx767 (318 AA) 4.0 days 1.20 (381) n.d. 2.26 (718) 
Tx812 (204 AA) 3.8 days 0.99 (201) 1.30 (265) 1.77 (360) 
 
Table 2: Number of identified residue pairs >11 residues apart in protein 
sequence  
Target protein 5% FDR 5-10% FDR 10-20% FDR 
HSA (585 AA) 330 (66%)1 292 (77%) 511 (83%) 
Tx781 (420 AA) 189 (62%) 100 (72%) 99 (82%) 
Tx808 (418 AA) 155 (59%) 15 (71%) 52 (93%) 
Tx767 (318 AA) 277 (73%) n.d. 234 (69%) 
Tx812 (204 AA) 146 (73%) 48 (75%) 63 (66%) 
1 Number of links >11 residues apart (percentage of links >11 residues apart of all links) 
Table 3: Number of identified residue pairs added (at 5% FDR) with alternatives to 
trypsin-only digestion. 
Target protein 5% FDR total Glu-C digestiona % Glu-C identified 
of total 
Tx781 (420 AA) 305 119 39% 
Of this in N-
term. 180 AA 
77 57 74% 
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Tx808 (418 AA) 265 45 17% 
Tx767 (318 AA) 381 111 29% 
Tx812 (204 AA) 201 36 18% 
aAll digestion methods involving use of Glu-C (including trypsin/Glu-C co-digestion 
(Tx781 and Tx808), and in-solution Glu-C digestion (Tx808, Tx767 and Tx812). 
